[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 640
Citations 0
Comment & Response
January 27, 2015

Heterogeneity in Meta-analysis of FDG-PET Studies to Diagnose Lung Cancer

Author Affiliations
  • 1Stanford Prevention Research Center, Stanford University, Stanford, California
  • 2Department of Public Health and Community Medicine, Tufts University, Boston, Massachusetts
  • 3School of Population and Public Health, University of British Columbia, Vancouver, Canada
JAMA. 2015;313(4):419. doi:10.1001/jama.2014.16482

To the Editor Dr Deppen and colleagues1 conducted a large meta-analysis that showed the limitations of lung cancer diagnosis using fludeoxyglucose F 18 combined with positron emission tomography (FDG-PET) in areas with endemic infectious lung disease. Although the sensitivity and specificity of FDG-PET diagnosis was heterogeneous across the included studies, thereby compromising interpretation of the pooled results, the relevance of presenting an I2 statistic to underscore and interpret the extent of the heterogeneity should be questioned.

First Page Preview View Large
First page PDF preview
First page PDF preview
×